Assessment of Different Mathematical Models for Calculating and Expressing the Results of Coagulation Test Procedures

Summary

Coagulation activity, expressed as percentage of normal and as clotting time ratio, was estimated in 220 specimens from patients on long-term anticoagulant treatment by 3 different coagulation test procedures, i.e. Thrombotest, Simplastin-A and Normotest. The estimates were calculated from the same determinations.

The distribution of percentage values showed a fairly pronounced deviation from normality. After logarithmic transformation, the distribution was normalized, the regression lines between Thrombotest and other tests became parallel, and that between PIVKA-insensitive systems was shifted to a 45° line. Logarithmic transformation also stabilized the residual variance. These features make percentage values accessible for treatment according to the standard methods of bioassay statistics.

Attempts to normalize the distribution of ratio values by various transformations were unsuccessful. Formal analysis of data revealed a variation in the proportionality of ratio values with the level of estimated coagulation defect. This may restrict the usefulness of the ratio approach. Logarithmic transformation partly reduced the discrepancy.

• References

• 1 Biggs R. 1965; Report on the standardisation of the one-stage prothrombin time for the control of anticoagulant therapy. Thrombosis et Diathesis Haemorrhagica 17: 303.
• 2 Biggs R, and Denson K. W. E. 1967; Standardization of the one-stage prothrombin time for the control of anticoagulant therapy. British Medical Journal 1: 84.
• 3 Fisher R. A. 1954. Statistical Methods for Research Workers. 12th edn.. Oliver & Boyd; Edinburgh & London:
• 4 Hemker H. C, Veltkamp J. J, Hensen A, and Loeliger E. A. 1963; Nature of prothrombin biosynthesis, preprothrombinaemia in vitamin K-deficiency. Nature 200: 589.
• 5 Kahan J, and Norén I. 1975; Use of a lyophilized reference plasma to compare coagulation assay procedures (Normotest, Simplastin-A and Thrombotest). Thrombosis et Diathesis Haemorrhagica 34: 426.
• 6 Leck L, Gowland E, and Poller L. 1974; The variability of measurements of the prothrombin time ratio in the national quality control trials : a follow-up study. British Journal of Haematology 28: 601.
• 7 Littell A. S. 1967; Statistical considerations in selecting a thromboplastin preparation as a standard. Thrombosis et Diathesis Haemorrhagica Suppl.26: 441.
• 8 Littell A. S, and Ratnoff O. D. 1969; A comparative study of several thromboplastins used to measure the one-stage prothrombin time. Thrombosis et Diathesis Haemorrhagica Suppl.35: 135.
• 9 Loeliger E. A, and Hemker H. C. 1970; Standardization in the laboratory control of oral anticoagulants. Thrombosis et Diathesis Haemorrhagica Suppl.40: 359.
• 10 Loeliger E. A, Taconis W. K, Veltkamp J. J, and Hemker H. C. 1970; Standardization of results obtained with different thromboplastin preparations. Thrombosis et Diathesis Haemorrhagica 39: 369.
• 11 Murphy E. A. 1969; On the use of ratios in the thromboplastin test. Thrombosis et Diathesis Haemorrhagica Suppl.35: 125.
• 12 Poller L, Thomson J. M, and Alderson M. R. 1971; The British system for anticoagulant control and Thrombotest. Journal of Clinical Pathology 24: 143.